drugset / Trial / NCT02844725

Evaluate the Analgesic Efficacy and Safety of VVZ-149 Injection for Post-operative Pain Following Gastrectomy

NCT02844725

Phase 2 Completed 60 enrolled Vivozon, Inc.
RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of this phase 2 study is to evaluate the efficacy and safety of an analgesic drug candidate, VVZ-149 Injections. The study is designed as randomized, double-blind, parallel, and placebo-controlled study.

Timeline

Start
2016-06
Primary completion
2017-02
Completion
2017-02

Drugs

EvaluationDrugModalityDoseRoute
Subject VVZ-149 Small molecule 1.3 mg/kg Intravenous

Indications

No indication recorded.